Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 62, 2007 - Issue 5
55
Views
0
CrossRef citations to date
0
Altmetric
Papers of the lectures presented at the Annual Congress of the Belgian Society for Internal Medicine

EMERGING AND RE-EMERGING INFECTIOUS DISEASES

&
Pages 337-341 | Published online: 09 Jan 2014

REFERENCES

  • Fauci AS. Emerging and Reemerging Infectious Diseases: The PerpetuaE Challenge. Acad Med 2005; 80: 1079–85.
  • Borchardt SM, Ritger KA, Dworkin MS. Categorization, Prioritiza-tion and Surveillance of PotentiaE Bioterrorism Agents. InfectDis Clin N Am 2006; 20:213–25.
  • Zeto[a N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticiffin-resistant Staphy[ococcus aureus : an emerg-ing threat. Lancet Infect Dis 2005; 5:275–86.
  • Daum RS. Skin and Soft-Tissue Infections Caused by Methicik [in-Resistant Staphybcoccus aureus. N Engl I Med 2007; 357: 380–90.
  • BartEett JG. Narrative Review:The New Epidemic of CEostridium difficiEe-Associated Enteric Disease. Ann Intern Med. 2006; 145: 758–64.
  • AsEam S, Hamill RJ, Musher DM. Treatment of CEostridium diffi-clle-associated disease: oEcl therapies and new strategies.Lancet Infect Dis 2005; 5:549–57.
  • Pepin J, Mary ME, Valiquette L, et al Increasing Risk of Re[apse after Treatment of CEostridium difficiEe Colitis in Quebec, Canada. Clin Infect Dis 2005; 40: 1591–7.
  • Loo VG, Poirier L, Miller MA, et al. A Predominantly Clonal Multi-Institutional Outbreak of Clostridium diffi cile-Associated Diarrhea with High Morbidity and Mortality. N Engl J Med 2005; 353: 2442–9.
  • Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium diffi cile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366: 1079–84.
  • Zar FA, Bakkanagari SR, Moorthi KMLST, David MB. A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium diffi cile-Associated Diarrhea, Stratifi ed by Disease Severity. Clin Infect Dis 2007; 45: 302–7.
  • Kuijper EJ, Van Dissel JT, Wilcox MH. Clostridium diffi cile: changing epidemiology and new treatment options. Curr Opin Infect Dis 2007; 20: 376–83.
  • McPherson S, Rees CJ, Ellis R, Soo S, Panter SJ. Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium diffi cile Diarrhea. Dis Colon Rectum 2006; 49: 640–5.
  • Sasse A, Defraye A, Ducoffre G. Recent syphilis trends in Belgium and enchancement of STI surveillance systems. Euro Surveill 2004; 9: 6–8.
  • Peterman TA, Furness BW. The resurgence of syphilis among men who have sex with men. Curr Opin Infect Dis 2007; 20: 54–9.
  • Zetola NM, Klausner JD. Syphilis and HIV Infection: An Update. Clin Infect Dis 2007; 44: 1222–8.
  • Matthyssen P, Van Wijngaerden E, Lagrou K, Peetermans W. Sy-fills. Tijdschr Geneeskd 2006; 62: 339–47.
  • Workowski KA, Berman SM. Sexua RyTransmitted Diseases Treat-ment Guidelines, 2006. MMWR 2006; 55: RR–11.
  • Leder K, Tong S, Weld L, et al. for the GeoSentinel Surveillance Network. Illness in Travelers Visiting Friends and Relatives: A Review of the GeoSentinel Surveillance Network. Clin lnfec Dis 2006; 43: 1185–93.
  • Wilson MA,Weld LH, Boggild A, et al. for the GeoSentinel Surveil-lance Network. Fever in Returned Travelers: Results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44: 1560–8.
  • Freedman DO, Weld LH, Kozarsky PE, et al. for the GeoSentinel Surveillance Network. Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers. N Engl I Med 2006; 354:119–30.
  • Bottieau E, Clerinx J, Schrooten W, et al.. Etiology and Outcome of Fever After a Stay in the Tropics. Arch Intern Med 2006; 166: 1642–8.
  • Pialoux G,GaLithe BA, Jauréguiberry S, Strobel M. Chikungunya, an epidemic a rbovirosis. Lancet Infect Dis 2007; 7:319–27.
  • Gibbons RV, Vaughn DW. Dengue: an escalating problem. BM' 2002; 324: 1563–6.
  • Wilder-Smith A, Schwartz E. Dengue in Travelers. N Engl j Med 2005; 353: 924–32.
  • Webster RG, Govorkova EA. H5N1 Influenza -Continuing Evolu-tion and Spread. N Eng(' Med 2006; 355: 2174–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.